Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01018498 · ClinicalTrials.gov registry record · NA

Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome

A NA study of Irritable Bowel Syndrome, sponsored by Baylor College of Medicine.

Completed
Registry status
NA
Development phase
12
Enrollment target
2
Study locations

NCT01018498 is a NA study of Irritable Bowel Syndrome that has completed, run by Baylor College of Medicine. The registered enrollment target is 12 participants, below the 144-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01018498, a NA study of Irritable Bowel Syndrome, has completed, sponsored by Baylor College of Medicine.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
2
Study locations

Study Summary

Malabsorption of certain foods (e.g. lactose) has been proposed as a cause of irritable bowel syndrome in adults and children. Recently, a diet that lowers intake of a combination of foods has been found to be effective in adults with IBS identified with fructose malabsorption. The purpose of this study is to determine whether a restricted fermentable substrate diet is effective in the treatment of irritable bowel syndrome in children.

Conditions Studied

Interventions

  • BEHAVIORAL Restricted FODMAPs diet

Study Locations (2)

Texas

  • Children's Nutrition Research Center - Houston
  • Texas Children's Hospital - Houston

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2009-10
Est. Completion 2011-09
Phase NA

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT01018498

The ClinicalTrials.gov registry entry for NCT01018498 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 144-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (92% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Restricted FODMAPs diet is the first listed.

NCT01018498 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01018498 about?

NCT01018498 is a clinical study titled "Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome". Malabsorption of certain foods (e.g. lactose) has been proposed as a cause of irritable bowel syndrome in adults and children. Recently, a diet that lowers intake of a combination of foods has been found to be effective in adults with IBS identified with fructose malabsorption. The purpose of this ...

What is the current status of trial NCT01018498?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2009-10. Estimated completion is 2011-09.

What conditions does trial NCT01018498 study?

This clinical trial studies the following conditions: Irritable Bowel Syndrome.

What interventions are being tested in trial NCT01018498?

The interventions under investigation include: Restricted FODMAPs diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT01018498?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01018498 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Irritable Bowel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.